WASHINGTON, July 9 -- Sen. Charles E. Grassley, R-Iowa, issued the following news release:

Sen. Chuck Grassley (R-Iowa) today welcomed the Federal Trade Commission (FTC)'s interim staff report on opaque pharmacy benefit manager (PBM) practices. The interim report is a direct result of Grassley's request for a 6(b) study on potential anti-competition in the prescription drug industry, as well as his bipartisan demands for a status update in light of FTC's significant delays.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products